K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Reinhard Dummer
also known as Dummer, R, Dummer, R., Dummer, Reinhard
University Hospital of Zurich · AstraZeneca (United Kingdom) · Goethe University Frankfurt · Roche (Switzerland)
About this author
Works
2,770
Cited by
128,618
h-index
154
i10
855
ORCID ↗
Top papers
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González, et al.
·
2015
·
New England Journal of Medicine
↗ 8,092
OA
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert, et al.
·
2011
·
New England Journal of Medicine
↗ 7,670
OA
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González, et al.
·
2017
·
New England Journal of Medicine
↗ 5,360
OA
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González, et al.
·
2019
·
New England Journal of Medicine
↗ 3,665
OA
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen, Diana Miao, Bastian Schilling, et al.
·
2015
·
Science
↗ 2,948
OA
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Frank O. Nestlé, Selma Alijagic, Michel Gilliet, et al.
·
1998
·
Nature Medicine
↗ 2,863
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert, Bogusława Karaszewska, Jacob Schachter, et al.
·
2014
·
New England Journal of Medicine
↗ 2,638
OA
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty, Caroline Robert, Peter Hersey, et al.
·
2012
·
New England Journal of Medicine
↗ 2,136
OA
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas, Igor Puzanov, Reinhard Dummer, et al.
·
2015
·
The Lancet Oncology
↗ 1,556
OA
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas, Reinhard Dummer, Igor Puzanov, et al.
·
2017
·
Cell
↗ 1,467
OA
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
Georgina V. Long, Axel Hauschild, Mario Santinami, et al.
·
2017
·
New England Journal of Medicine
↗ 1,465
OA
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen, Jesse S. Boehm, So Young Kim, et al.
·
2010
·
Nature
↗ 1,446
OA
Books
Physikalische Therapiemaßnahmen in der Dermatologie
2003
·
Steinkopff-Verlag Darmstadt
Dermatologische Onkologie
2013
·
Springer London, Limited
Dermatologische Onkologie (German Edition)
2011
·
Springer
Skin Cancer - A World-Wide Perspective
2011
·
Springer
Medikamentöse Therapie maligner Erkrankungen.
2001
·
Urban & Fischer Verlag